Healthcare DIVE June 13, 2019
Kristin Jensen

Dive Brief:

  • IBM, Walmart, KPMG and Merck & Co. said the U.S. Food and Drug Administration chose them to be part of a blockchain pilot program designed to track and ensure the integrity of prescription medicines and vaccines.
  • The companies said they expect to complete the program in the fourth quarter of this year, with results slated for publication in an FDA report.
  • Participants “will evaluate next steps” after the conclusion of the pilot, the companies said in a joint statement Thursday.
Dive Insight:

The four industry powerhouses are the latest to tackle the need for an interoperable system that can track and trace medications across the supply...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Blockchain, FDA, Govt Agencies, Technology
Blockchain in Health - From Pilots to Mainstream and Implications for AI
PharmaLedger Association – Platform Launch Lessons Learned and Outlook
Developing a Secure Internet-based Network of Trusted Data
EHR Systems and Blockchain: Potentials, Challenges and the Road Ahead
Data Economy in Healthcare on Blockchain Technology

Share This Article